In vitro studies using human colon cancer cells reveal that muscarinic receptor agonists stimulate cell proliferation, survival, migration, and invasion by complex mechanisms involving interacting post-M3R signaling pathways as well as cross-talk which activates epidermal growth factor receptors (EGFR) and a different set of post-receptor signaling cascades [11]. Here, EGFR is linked to colonic neoplasm.